Cameroon vs Netherlands: Antiretroviral therapy coverage for PMTCT
Cameroon
59.0%
in 2024
Netherlands
55.0%
in 2009
Cameroon rank
62nd
Netherlands rank
64th
Antiretroviral therapy coverage for PMTCT over time
- Cameroon
- Netherlands
How they compare
Cameroon currently reports 59.0% against 55.0% in Netherlands, a difference of 4.0%.
That makes Cameroon's figure about 1.1 times Netherlands's.
Across all 10 years both countries report, Netherlands has been ahead every year.
Cameroon ranks 62nd and Netherlands ranks 64th of 84 countries.
Netherlands has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Cameroon or Netherlands?
- Cameroon, at 59.0% against 55.0% in Netherlands as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Cameroon and Netherlands?
- 4.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Netherlands?
- 10 years are reported by both, from 2000 to 2009.
- How do Cameroon and Netherlands rank globally for antiretroviral therapy coverage for pmtct?
- Cameroon ranks 62nd and Netherlands ranks 64th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).